戻る Agenda
SESSION 1: Middle East & North Africa Townhall
Session Chair(s)
Amira Deia Younes
Director-Eastern Europe, Middle East & Africa (EEMEA) Global Regulatory Policy
MSD, United Arab Emirates
Sara Torgal, MPharm
Global Regulatory Policy Lead
DIA, Switzerland
Overview: In this session, a representative from each Health Authority in the MENA region will share updates, developments and future plans, followed by an interactive Panel Discussion.
Speaker(s)
Overall Strategic Trends and Policy Priorities in the Middle East & Africa
Amira Deia Younes
MSD, United Arab Emirates
Director-Eastern Europe, Middle East & Africa (EEMEA) Global Regulatory Policy
Reflections from the Health Authorities in the MENA region on their Recent Biggest Achievements and Key Priorities for the Future
Aisha Al Ansari
Ministry of Public Health, Qatar, Qatar
Director, Pharmacy and Drug Control Department
Reflections from the Health Authorities in the MENA region on their Recent Biggest Achievements and Key Priorities for the Future
Donia Al Bastaki
Ministry of Health, Drug and Food Control, Kuwait
Head of Registration Department, Pharmaceutical & Herbal Medicines Registration
Reflections from the Health Authorities in the MENA region on their Recent Biggest Achievements and Key Priorities for the Future
Tamer El-Hossieny
Egyptian Drug Authority (EDA), Egypt
Vice Chairman
Reflections from the Health Authorities in the MENA region on their Recent Biggest Achievements and Key Priorities for the Future
Shatha Ziad Al-Quraan
Jordan Food and Drug Administration (JFDA), Jordan
Head - Chemical Drug Registration Department
Reflections from the Health Authorities in the MENA region on their Recent Biggest Achievements and Key Priorities for the Future
Nancy Yang Ngum
African Union Development Agency (AUDA-NEPAD), South Africa
Public Health Officer (Public Health Expert)
Panel Discussion with Q&A (With the additional participation of):
Speaker(s) / Representative(s) Invited
Qatar